Associate Director, Pathology

Role Summary

The successful pathologist candidate will join an experienced team of pathologists providing discovery and development support on a strong pipeline of programs covering a large breadth of disease areas. In addition to routine pathology evaluation, there will be a strong emphasis on supporting research with a collaborative team of clinical pathology, histology and molecular pathology scientists. This position is onsite in Kendall Square, Cambridge, though hybrid onsite will be considered.

Responsibilities

• Support in vivo discovery studies including model and endpoint selection, data analysis, and molecular pathology including IHC/ISH interpretation.
• Interface with and support pathology needs of Platform/Research scientists.
• Conduct gross and microscopic examination of animal tissues, interpret and determine significance of results for histopathology, molecular pathology and clinical pathology.
• Providing support for all in vivo platform and therapeutic endeavors in rodents and nonhuman primates.
• Provide written pathology reports, memos, and other communications that accurately and concisely reflect the data collected and the impact on target feasibility, opportunities and risks, development considerations, and human safety.
• Summarize experimental results for presentations within and outside the company.
• Hone toxicologic pathology skills to serve as program pathologist conducting pathology peer reviews of GLP studies.
• May assist in the regulatory toxicology strategy, guiding development and project prioritization by responding quickly to data from ongoing studies and providing input to management and development teams.
• Ongoing career development support as experience grows.

Qualifications

• Doctor of Veterinary Medicine (DVM/VMD/BVSc).
• ACVP/ECVP-board certification in anatomic pathology.
• PhD strongly preferred.
• >2 years of experience as a pathologist in biotech, pharma or at a CRO preferable.
• Excellent English oral and written communication skills.
• Strong interest in areas of Alnylam research emphasis.